Page last updated: 2024-10-24

carteolol and Body Weight

carteolol has been researched along with Body Weight in 11 studies

Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.

Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.

Research Excerpts

ExcerptRelevanceReference
"Carteolol treatment increased beta-adrenergic receptor density, and the high carteolol dose restored SR Ca2+-ATPase and myofibrillar ATPase activities, along with creatine kinase, lactate dehydrogenase, aspartate transaminase, and ATP synthase activities, to normal."5.30Cellular and molecular remodeling in a heart failure model treated with the beta-blocker carteolol. ( Bristow, MR; DiSalvo, TG; Gwathmey, JK; Hajjar, RJ; Khan, F; Kim, CS; Matsumori, A, 1999)
" The beta-blocking potency, estimated from the area under the dose-response curve (beta-blocking action) of carteolol, was also 300 times greater than that of propranolol and correlated well with the extent of the structural changes in the heart."5.27Dose-related inhibitory effects of the beta-adrenoceptor blocking drugs carteolol and propranolol on cardiac hypertrophy in spontaneously hypertensive rats. ( Igawa, T; Ikezono, K; Kimura, Y; Watanabe, K, 1984)
"Carteolol was shown to be safe and well tolerated by most patients."5.27Carteolol treatment of essential hypertension: a long-term study of safety and efficacy. ( Klepper, MJ; Luther, RR; Maurath, CJ; Peckinpaugh, RO; Ringham, GL, 1986)
"To determine whether beta blockade protects against the acceleration of lipid peroxidation in hyperthyroid rat soleus (slow-oxidative) muscle, in vivo chronic (3 weeks) effects of 3 beta blockers with different ancillary properties on mitochondrial oxidative enzymes, antioxidant enzymes, and thiobarbituric acid-reactive substances were investigated."3.68Differential effects of 3 beta blockers on lipid peroxidation in hyperthyroid muscle. ( Asayama, K; Dobashi, K; Hayashibe, H; Kato, K, 1990)
"Carteolol treatment increased beta-adrenergic receptor density, and the high carteolol dose restored SR Ca2+-ATPase and myofibrillar ATPase activities, along with creatine kinase, lactate dehydrogenase, aspartate transaminase, and ATP synthase activities, to normal."1.30Cellular and molecular remodeling in a heart failure model treated with the beta-blocker carteolol. ( Bristow, MR; DiSalvo, TG; Gwathmey, JK; Hajjar, RJ; Khan, F; Kim, CS; Matsumori, A, 1999)
"Metoprolol did not cause any significant changes compared with the control group."1.28Beta-blocker treatment of dilated cardiomyopathy. Beneficial effect of carteolol in mice. ( Kawai, C; Matsumori, A; Okada, I; Tominaga, M; Yamada, T, 1991)
"Carteolol was added to the drinking water in doses of 0."1.28Systemic effects of carteolol, a beta-adrenoceptor antagonist in stroke-prone spontaneously hypertensive rats. ( Niwa, M; Ohkubo, T; Ohta, H; Ozaki, M; Shigematsu, K; Uchida, S; Yamashita, K, 1990)
" The beta-blocking potency, estimated from the area under the dose-response curve (beta-blocking action) of carteolol, was also 300 times greater than that of propranolol and correlated well with the extent of the structural changes in the heart."1.27Dose-related inhibitory effects of the beta-adrenoceptor blocking drugs carteolol and propranolol on cardiac hypertrophy in spontaneously hypertensive rats. ( Igawa, T; Ikezono, K; Kimura, Y; Watanabe, K, 1984)
"Carteolol was shown to be safe and well tolerated by most patients."1.27Carteolol treatment of essential hypertension: a long-term study of safety and efficacy. ( Klepper, MJ; Luther, RR; Maurath, CJ; Peckinpaugh, RO; Ringham, GL, 1986)
"Carteolol was administered orally by gastric intubation at 3, 15, 75 or 150 mg/kg/day to ICR-JCL mice of both sexes prior to mating and to females during early stage of pregnancy to determine its effects on the entire reproductive process and fetal development."1.26Reproduction study of carteolol hydrochloride in mice. Part I. Fertility and reproductive performance. ( Nakatsu, I; Shingai, F; Tamagawa, M; Tanaka, N, 1979)
"Carteolol was orally administered to mice once a day at doses of 3, 30 and 150 mg/kg/day during the perinatal and lactation periods and evaluated on its adverse effects on pregnant animals and their offspring."1.26Reproduction study of carteolol hydrochloride in mice. Part 2. Peri -and postnatal toxicity. ( Nishino, H; Numoto, T; Tamagawa, M; Tanaka, N, 1979)

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19904 (36.36)18.7374
1990's7 (63.64)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Igawa, T1
Ikezono, K1
Watanabe, K1
Kimura, Y1
Takahashi, H1
Nakano, K1
Yasuda, T1
Komiyama, Y1
Murakami, T1
Nishimura, M1
Nakanishi, T1
Sakamoto, M1
Nanbu, A1
Yoshimura, M1
Saitoh, Y1
Tani, T1
Asahi, Y1
Man, Z1
Kawano, K1
Ikunaga, H1
Gwathmey, JK1
Kim, CS1
Hajjar, RJ1
Khan, F1
DiSalvo, TG1
Matsumori, A2
Bristow, MR1
Tanaka, N2
Shingai, F1
Tamagawa, M2
Nakatsu, I1
Numoto, T1
Nishino, H1
Tominaga, M1
Okada, I1
Yamada, T1
Kawai, C1
Asayama, K1
Hayashibe, H1
Dobashi, K1
Kato, K1
Hasui, K1
Ohmoto, T1
Tamaki, T1
Fukui, K1
Iwao, H1
Abe, Y1
Yamashita, K1
Ohta, H1
Uchida, S1
Shigematsu, K1
Ohkubo, T1
Niwa, M1
Ozaki, M1
Luther, RR1
Maurath, CJ1
Klepper, MJ1
Peckinpaugh, RO1
Ringham, GL1

Other Studies

11 other studies available for carteolol and Body Weight

ArticleYear
Dose-related inhibitory effects of the beta-adrenoceptor blocking drugs carteolol and propranolol on cardiac hypertrophy in spontaneously hypertensive rats.
    European journal of pharmacology, 1984, Sep-03, Volume: 104, Issue:1-2

    Topics: Animals; Body Weight; Cardiomegaly; Carteolol; Dose-Response Relationship, Drug; Drinking; Heart Rat

1984
Anti-obesity and anti-diabetic effects of carteolol in non-insulin-dependent diabetic mice.
    Clinical and experimental pharmacology & physiology, 1994, Volume: 21, Issue:6

    Topics: Adipose Tissue, Brown; Animals; Blood Pressure; Body Weight; Carbohydrate Metabolism; Cardiac Output

1994
Improving effect of carteolol on bodyweight and carbohydrate and lipid metabolic responses in the OLETF rat.
    Clinical and experimental pharmacology & physiology, 1997, Volume: 24, Issue:5

    Topics: Adipose Tissue; Adrenergic beta-Antagonists; Animals; Blood Glucose; Body Weight; Carteolol; Cholest

1997
Cellular and molecular remodeling in a heart failure model treated with the beta-blocker carteolol.
    The American journal of physiology, 1999, Volume: 276, Issue:5

    Topics: Adenosine Triphosphate; Adenylyl Cyclases; Adrenergic beta-Antagonists; Animals; Blood Pressure; Bod

1999
Reproduction study of carteolol hydrochloride in mice. Part I. Fertility and reproductive performance.
    The Journal of toxicological sciences, 1979, Volume: 4, Issue:1

    Topics: Animals; Behavior, Animal; Body Weight; Bone Development; Carteolol; Feeding Behavior; Female; Ferti

1979
Reproduction study of carteolol hydrochloride in mice. Part 2. Peri -and postnatal toxicity.
    The Journal of toxicological sciences, 1979, Volume: 4, Issue:1

    Topics: Animals; Animals, Newborn; Body Weight; Carcinogens; Carteolol; Feeding Behavior; Female; Fetus; Ges

1979
Beta-blocker treatment of dilated cardiomyopathy. Beneficial effect of carteolol in mice.
    Circulation, 1991, Volume: 83, Issue:6

    Topics: Adrenergic beta-Antagonists; Animals; Body Weight; Cardiomyopathy, Dilated; Carteolol; Drug Evaluati

1991
Differential effects of 3 beta blockers on lipid peroxidation in hyperthyroid muscle.
    Endocrinologia japonica, 1990, Volume: 37, Issue:4

    Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Body Weight; Carteolol; Hyperthyroidism; Lipid Perox

1990
Effects of prolonged treatment with beta-adrenoceptor antagonist, carteolol on systemic and regional hemodynamics in stroke-prone spontaneously hypertensive rats.
    Journal of pharmacobio-dynamics, 1991, Volume: 14, Issue:2

    Topics: Animals; Blood Pressure; Body Weight; Cardiac Output; Carteolol; Cerebrovascular Disorders; Hemodyna

1991
Systemic effects of carteolol, a beta-adrenoceptor antagonist in stroke-prone spontaneously hypertensive rats.
    Journal of pharmacobio-dynamics, 1990, Volume: 13, Issue:1

    Topics: Adrenal Glands; Adrenergic beta-Antagonists; Animals; Aorta, Abdominal; Blood Pressure; Blood Urea N

1990
Carteolol treatment of essential hypertension: a long-term study of safety and efficacy.
    The Journal of international medical research, 1986, Volume: 14, Issue:4

    Topics: Adult; Aged; Body Weight; Carteolol; Electrocardiography; Female; Humans; Hypertension; Male; Middle

1986